AI Signal & Stock Analysis · Weak ↓
As of Aug 14 2026, 1:04 PM, AkshayaAI's signal for AZN is Weak ↓; the stock is at $156.09 (-0.73% today); neutral (RSI 34); technical trend is down-trend; news sentiment is nan.
Data as of Aug 14 2026, 1:04 PM. Informational analytics only — not investment advice.
| AI signal (Strength) | Weak ↓ |
|---|---|
| Price | $156.09 |
| Change today | -0.73% |
| RSI (14) | 34.15 |
| Relative volume | 1.12 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | $242.1B |
| Forward P/E | 13.56 |
| 52-week high | -26.6% away |
| 52-week low | +6.8% above |
| Technical trend | Down-trend (since 2024-01-26) |
| News sentiment | Nan |
| Sector | Healthcare-Genetherapy |
| Next earnings | 7/27/2026 8:30:00 AM |
As of Aug 14 2026, 1:04 PM, AkshayaAI assigns AZN (Astrazeneca plc) a Weak signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.
AZN's RSI is neutral (RSI 34). A reading above 70 is typically considered overbought and below 30 oversold.
AZN is trading about 27% below its 52-week high and 7% above its 52-week low as of Aug 14 2026, 1:04 PM.
AZN's next earnings date is 7/27/2026 8:30:00 AM.
AZN is classified under Healthcare-Genetherapy in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 1:04 PM and may not reflect real-time prices. Always do your own research.
Instant, data-backed answers — free to try.